T
Takeo Nomi
Researcher at Nara Medical University
Publications - 87
Citations - 2308
Takeo Nomi is an academic researcher from Nara Medical University. The author has contributed to research in topics: Hepatectomy & Hepatocellular carcinoma. The author has an hindex of 20, co-authored 80 publications receiving 1888 citations.
Papers
More filters
Journal ArticleDOI
Clinical Significance and Therapeutic Potential of the Programmed Death-1 Ligand/Programmed Death-1 Pathway in Human Pancreatic Cancer
Takeo Nomi,Masayuki Sho,Takahiro Akahori,Kaoru Hamada,Atsushi Kubo,Hiromichi Kanehiro,Shinji Nakamura,Koji Enomoto,Hideo Yagita,Miyuki Azuma,Yoshiyuki Nakajima +10 more
TL;DR: The data suggest for the first time that PD-L1 status may be a new predictor of prognosis for patients with pancreatic cancer and provide the rationale for developing a novel therapy of targeting thePD-L/PD-1 pathway against this fatal disease.
Journal ArticleDOI
Clinical importance of B7-H3 expression in human pancreatic cancer
Ichiro Yamato,Masayuki Sho,Takeo Nomi,Takahiro Akahori,Keiji Shimada,Kiyohiko Hotta,Kiyohiko Hotta,Hiromichi Kanehiro,Noboru Konishi,Hideo Yagita,Y Nakajima +10 more
TL;DR: Tumour-related B7-H3 expression was abundant in most human pancreatic cancer tissues and was significantly higher compared with that in non-cancer tissue or normal pancreas; its expression was significantly more intense in cases with lymph node metastasis and advanced pathological stage.
Journal ArticleDOI
Laparoscopy Decreases Pulmonary Complications in Patients Undergoing Major Liver Resection: A Propensity Score Analysis.
David Fuks,François Cauchy,Samir Fteriche,Takeo Nomi,Lilian Schwarz,Safi Dokmak,Olivier Scatton,Grazia Fusco,Jacques Belghiti,Brice Gayet,Olivier Soubrane +10 more
TL;DR: Pure laparoscopy allows reducing PPCs in patients requiring major liver resection in patients undergoing OMH or LMH, and the overall incidence and types of postoperative pulmonary complications were significantly lower in the laparoscopic group than in the open group.
Journal ArticleDOI
A novel small-molecule compound targeting CCR5 and CXCR3 prevents acute and chronic allograft rejection
Satoru Akashi,Masayuki Sho,Hisanori Kashizuka,Kaoru Hamada,Naoya Ikeda,Yukiyasu Kuzumoto,Yoshikazu Tsurui,Takeo Nomi,Takashi Mizuno,Hiromichi Kanehiro,Michiyoshi Hisanaga,Saiho Ko,Yoshiyuki Nakajima +12 more
TL;DR: Antagonism of CCR5 and CXCR3 has a substantial therapeutic effect on inhibiting both acute and chronic allograft rejection and may be potential targets in clinical transplantation in the future.
Journal ArticleDOI
Pathological and clinical impact of neoadjuvant chemoradiotherapy using full-dose gemcitabine and concurrent radiation for resectable pancreatic cancer
Masayuki Sho,Takahiro Akahori,Toshihiro Tanaka,Shoichi Kinoshita,Tetsuro Tamamoto,Takeo Nomi,Ichiro Yamato,Daisuke Hokuto,Satoshi Yasuda,Chihiro Kawaguchi,Hideyuki Nishiofuku,Nagaaki Marugami,Yasunori Enomonoto,Takahiko Kasai,Masatoshi Hasegawa,Kimihiko Kichikawa,Yoshiyuki Nakajima +16 more
TL;DR: The current protocol of neoadjuvant chemoradiotherapy is feasible and substantially improves the pathology, however, it has some detrimental effects on postoperative nutritional status and performance of adjuvant chemotherapy.